Uveitis in Tumor Patients Treated with Immunological Checkpoint- and Signal Transduction Pathway-Inhibitors-Reference-Cited by-同舟云学术

Uveitis in Tumor Patients Treated with Immunological Checkpoint- and Signal Transduction Pathway-Inhibitors

Published:2021-05-13 Issue: Volume: Page:1-7
ISSN:0927-3948
Container-title:Ocular Immunology and Inflammation
language:en
Short-container-title:Ocular Immunology and Inflammation

Author:

Thurau Stephan¹,Engelke Hendrik¹,McCluskey Peter²,Symes Richard J.²,Whist Eline³,Teuchner Barbara⁴,Haas Gertrud⁴,Allegri Pia⁵,Cimino Luca⁶^ORCID,Bolletta Elena⁶,Miserocchi Elisabetta⁷,Russo Marinella⁷,Li Jeany Q.⁸,Heiligenhaus Arnd⁹^ORCID,Wildner Gerhild¹

Affiliation:

1. Department of Ophthalmology, University Hospital, LMU Munich, Munich, Germany

2. Ophthalmology, Save Sight Institute, University of Sydney, Sydney, NSW, Australia

3. Ophthalmology Department, Royal Darwin Hospital, Tiwi, Australia

4. Department of Ophthalmology, Medical University of Innsbruck, Innsbruck, Austria

5. Inflammatory Eye Diseases Referral Center, Rapallo Hospital, Genova, Italy

6. Ocular Immunology Unit, Azienda USL-IRCCS, Reggio Emilia, Italy

7. Ocular Immunology and Uveitis Service, Department of Ophthalmology, San Raffaele Scientific Institute, University Vita-Salute, Milano, Italy

8. Department of Ophthalmology, University Hospital Bonn, Bonn, Germany

9. Department of Ophthalmology, St. Franziskus Hospital, Münster, University of Duisburg-Essen, Germany

Funder

funding

Publisher

Informa UK Limited

Subject

Ophthalmology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/09273948.2021.1910850

Reference37 articles.

1. Introduction to checkpoint inhibitors and cancer immunotherapy

2. Low Surface Expression of B7-1 (CD80) Is an Immunoescape Mechanism of Colon Carcinoma

3. Rheumatologic symptoms in oncologic patients on PD-1 inhibitors

4. Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline

5. Checkpoint inhibitor-induced uveitis: a case series

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real‐World Incidence of Incident Noninfectious Uveitis in Patients Treated With BRAF Inhibitors: A Nationwide Clinical Cohort Study;American Journal of Ophthalmology;2024-11

2. Diagnosing and Managing Uveitis Associated with Immune Checkpoint Inhibitors: A Review;Diagnostics;2024-02-04

3. Pathogenese der Uveitis;Spektrum der Augenheilkunde;2024-02-01

4. Vogt-Koyanagi-Harada-like Syndrome Induced by Checkpoint Inhibitor Cemiplimab;Journal of Immunotherapy;2023-05-26

5. Okuläre Nebenwirkungen moderner onkologischer Therapie;Die Ophthalmologie;2023-05